zosuquidar trihydrochloride has been researched along with norfluoxetine in 1 studies
| Studies (zosuquidar trihydrochloride) | Trials (zosuquidar trihydrochloride) | Recent Studies (post-2010) (zosuquidar trihydrochloride) | Studies (norfluoxetine) | Trials (norfluoxetine) | Recent Studies (post-2010) (norfluoxetine) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 275 | 33 | 69 |
| Protein | Taxonomy | zosuquidar trihydrochloride (IC50) | norfluoxetine (IC50) |
|---|---|---|---|
| Potassium channel subfamily K member 2 | Homo sapiens (human) | 9 | |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | 0.8 | |
| Potassium voltage-gated channel subfamily C member 1 | Rattus norvegicus (Norway rat) | 0.8 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.2909 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J | 1 |
1 other study(ies) available for zosuquidar trihydrochloride and norfluoxetine
| Article | Year |
|---|---|
Inhibition of P-glycoprotein by newer antidepressants.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection | 2003 |